Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2000 Nov;59(Suppl 1):i90–i93. doi: 10.1136/ard.59.suppl_1.i90

Activation of cytokines as a mechanism of disease progression in heart failure

B Bozkurt
PMCID: PMC1766624  PMID: 11053097

Full Text

The Full Text of this article is available as a PDF (123.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anker S. D., Egerer K. R., Volk H. D., Kox W. J., Poole-Wilson P. A., Coats A. J. Elevated soluble CD14 receptors and altered cytokines in chronic heart failure. Am J Cardiol. 1997 May 15;79(10):1426–1430. doi: 10.1016/s0002-9149(97)00159-8. [DOI] [PubMed] [Google Scholar]
  2. Chung M. K., Gulick T. S., Rotondo R. E., Schreiner G. F., Lange L. G. Mechanism of cytokine inhibition of beta-adrenergic agonist stimulation of cyclic AMP in rat cardiac myocytes. Impairment of signal transduction. Circ Res. 1990 Sep;67(3):753–763. doi: 10.1161/01.res.67.3.753. [DOI] [PubMed] [Google Scholar]
  3. Dutka D. P., Elborn J. S., Delamere F., Shale D. J., Morris G. K. Tumour necrosis factor alpha in severe congestive cardiac failure. Br Heart J. 1993 Aug;70(2):141–143. doi: 10.1136/hrt.70.2.141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Ferrari R., Bachetti T., Confortini R., Opasich C., Febo O., Corti A., Cassani G., Visioli O. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation. 1995 Sep 15;92(6):1479–1486. doi: 10.1161/01.cir.92.6.1479. [DOI] [PubMed] [Google Scholar]
  5. Finkel M. S., Oddis C. V., Jacob T. D., Watkins S. C., Hattler B. G., Simmons R. L. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science. 1992 Jul 17;257(5068):387–389. doi: 10.1126/science.1631560. [DOI] [PubMed] [Google Scholar]
  6. Hegewisch S., Weh H. J., Hossfeld D. K. TNF-induced cardiomyopathy. Lancet. 1990 Feb 3;335(8684):294–295. doi: 10.1016/0140-6736(90)90115-l. [DOI] [PubMed] [Google Scholar]
  7. Kapadia S. R., Oral H., Lee J., Nakano M., Taffet G. E., Mann D. L. Hemodynamic regulation of tumor necrosis factor-alpha gene and protein expression in adult feline myocardium. Circ Res. 1997 Aug;81(2):187–195. doi: 10.1161/01.res.81.2.187. [DOI] [PubMed] [Google Scholar]
  8. Katz S. D., Rao R., Berman J. W., Schwarz M., Demopoulos L., Bijou R., LeJemtel T. H. Pathophysiological correlates of increased serum tumor necrosis factor in patients with congestive heart failure. Relation to nitric oxide-dependent vasodilation in the forearm circulation. Circulation. 1994 Jul;90(1):12–16. doi: 10.1161/01.cir.90.1.12. [DOI] [PubMed] [Google Scholar]
  9. Lancaster J. R., Jr, Laster S. M., Gooding L. R. Inhibition of target cell mitochondrial electron transfer by tumor necrosis factor. FEBS Lett. 1989 May 8;248(1-2):169–174. doi: 10.1016/0014-5793(89)80454-5. [DOI] [PubMed] [Google Scholar]
  10. Lenfant C. NHLBI funding policies. Enhancing stability, predictability, and cost control. Circulation. 1994 Jul;90(1):1–1. doi: 10.1161/01.cir.90.1.1. [DOI] [PubMed] [Google Scholar]
  11. Levine B., Kalman J., Mayer L., Fillit H. M., Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 1990 Jul 26;323(4):236–241. doi: 10.1056/NEJM199007263230405. [DOI] [PubMed] [Google Scholar]
  12. MacGowan G. A., Mann D. L., Kormos R. L., Feldman A. M., Murali S. Circulating interleukin-6 in severe heart failure. Am J Cardiol. 1997 Apr 15;79(8):1128–1131. doi: 10.1016/s0002-9149(96)00063-x. [DOI] [PubMed] [Google Scholar]
  13. Mann D. L., Young J. B. Basic mechanisms in congestive heart failure. Recognizing the role of proinflammatory cytokines. Chest. 1994 Mar;105(3):897–904. doi: 10.1378/chest.105.3.897. [DOI] [PubMed] [Google Scholar]
  14. Matsumori A., Shioi T., Yamada T., Matsui S., Sasayama S. Vesnarinone, a new inotropic agent, inhibits cytokine production by stimulated human blood from patients with heart failure. Circulation. 1994 Mar;89(3):955–958. doi: 10.1161/01.cir.89.3.955. [DOI] [PubMed] [Google Scholar]
  15. Matsumori A., Yamada T., Suzuki H., Matoba Y., Sasayama S. Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Br Heart J. 1994 Dec;72(6):561–566. doi: 10.1136/hrt.72.6.561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. McMurray J., Abdullah I., Dargie H. J., Shapiro D. Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure. Br Heart J. 1991 Nov;66(5):356–358. doi: 10.1136/hrt.66.5.356. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Milani R. V., Mehra M. R., Endres S., Eigler A., Cooper E. S., Lavie C. J., Jr, Ventura H. O. The clinical relevance of circulating tumor necrosis factor-alpha in acute decompensated chronic heart failure without cachexia. Chest. 1996 Oct;110(4):992–995. doi: 10.1378/chest.110.4.992. [DOI] [PubMed] [Google Scholar]
  18. Millar A. B., Foley N. M., Singer M., Johnson N. M., Meager A., Rook G. A. Tumour necrosis factor in bronchopulmonary secretions of patients with adult respiratory distress syndrome. Lancet. 1989 Sep 23;2(8665):712–714. doi: 10.1016/s0140-6736(89)90772-1. [DOI] [PubMed] [Google Scholar]
  19. Mohler E. R., 3rd, Sorensen L. C., Ghali J. K., Schocken D. D., Willis P. W., Bowers J. A., Cropp A. B., Pressler M. L. Role of cytokines in the mechanism of action of amlodipine: the PRAISE Heart Failure Trial. Prospective Randomized Amlodipine Survival Evaluation. J Am Coll Cardiol. 1997 Jul;30(1):35–41. doi: 10.1016/s0735-1097(97)00145-9. [DOI] [PubMed] [Google Scholar]
  20. Munger M. A., Johnson B., Amber I. J., Callahan K. S., Gilbert E. M. Circulating concentrations of proinflammatory cytokines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 1996 Apr 1;77(9):723–727. doi: 10.1016/s0002-9149(97)89206-5. [DOI] [PubMed] [Google Scholar]
  21. Neumann F. J., Ott I., Gawaz M., Richardt G., Holzapfel H., Jochum M., Schömig A. Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation. 1995 Aug 15;92(4):748–755. doi: 10.1161/01.cir.92.4.748. [DOI] [PubMed] [Google Scholar]
  22. Nishigaki K., Minatoguchi S., Seishima M., Asano K., Noda T., Yasuda N., Sano H., Kumada H., Takemura M., Noma A. Plasma Fas ligand, an inducer of apoptosis, and plasma soluble Fas, an inhibitor of apoptosis, in patients with chronic congestive heart failure. J Am Coll Cardiol. 1997 May;29(6):1214–1220. doi: 10.1016/s0735-1097(97)00055-7. [DOI] [PubMed] [Google Scholar]
  23. Oliff A., Defeo-Jones D., Boyer M., Martinez D., Kiefer D., Vuocolo G., Wolfe A., Socher S. H. Tumors secreting human TNF/cachectin induce cachexia in mice. Cell. 1987 Aug 14;50(4):555–563. doi: 10.1016/0092-8674(87)90028-6. [DOI] [PubMed] [Google Scholar]
  24. Pagani F. D., Baker L. S., Hsi C., Knox M., Fink M. P., Visner M. S. Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-alpha in conscious dogs. J Clin Invest. 1992 Aug;90(2):389–398. doi: 10.1172/JCI115873. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Parrillo J. E., Cunnion R. E., Epstein S. E., Parker M. M., Suffredini A. F., Brenner M., Schaer G. L., Palmeri S. T., Cannon R. O., 3rd, Alling D. A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy. N Engl J Med. 1989 Oct 19;321(16):1061–1068. doi: 10.1056/NEJM198910193211601. [DOI] [PubMed] [Google Scholar]
  26. Prichett G., Cohen H. J., Rao K. M., Cobb F., Sullivan M., Currie M. S. Tumor necrosis factor, natural killer activity and other measures of immune function and inflammation in elderly men with heart failure. Gerontology. 1995;41(1):45–56. doi: 10.1159/000213661. [DOI] [PubMed] [Google Scholar]
  27. Semb H., Peterson J., Tavernier J., Olivecrona T. Multiple effects of tumor necrosis factor on lipoprotein lipase in vivo. J Biol Chem. 1987 Jun 15;262(17):8390–8394. [PubMed] [Google Scholar]
  28. Suffredini A. F., Fromm R. E., Parker M. M., Brenner M., Kovacs J. A., Wesley R. A., Parrillo J. E. The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med. 1989 Aug 3;321(5):280–287. doi: 10.1056/NEJM198908033210503. [DOI] [PubMed] [Google Scholar]
  29. Testa M., Yeh M., Lee P., Fanelli R., Loperfido F., Berman J. W., LeJemtel T. H. Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension. J Am Coll Cardiol. 1996 Oct;28(4):964–971. doi: 10.1016/s0735-1097(96)00268-9. [DOI] [PubMed] [Google Scholar]
  30. Thaik C. M., Calderone A., Takahashi N., Colucci W. S. Interleukin-1 beta modulates the growth and phenotype of neonatal rat cardiac myocytes. J Clin Invest. 1995 Aug;96(2):1093–1099. doi: 10.1172/JCI118095. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Torre-Amione G., Kapadia S., Benedict C., Oral H., Young J. B., Mann D. L. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol. 1996 Apr;27(5):1201–1206. doi: 10.1016/0735-1097(95)00589-7. [DOI] [PubMed] [Google Scholar]
  32. Torre-Amione G., Kapadia S., Lee J., Bies R. D., Lebovitz R., Mann D. L. Expression and functional significance of tumor necrosis factor receptors in human myocardium. Circulation. 1995 Sep 15;92(6):1487–1493. doi: 10.1161/01.cir.92.6.1487. [DOI] [PubMed] [Google Scholar]
  33. Torre-Amione G., Kapadia S., Lee J., Durand J. B., Bies R. D., Young J. B., Mann D. L. Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. Circulation. 1996 Feb 15;93(4):704–711. doi: 10.1161/01.cir.93.4.704. [DOI] [PubMed] [Google Scholar]
  34. Wiedermann C. J., Beimpold H., Herold M., Knapp E., Braunsteiner H. Increased levels of serum neopterin and decreased production of neutrophil superoxide anions in chronic heart failure with elevated levels of tumor necrosis factor-alpha. J Am Coll Cardiol. 1993 Dec;22(7):1897–1901. doi: 10.1016/0735-1097(93)90776-w. [DOI] [PubMed] [Google Scholar]
  35. Yamauchi-Takihara K., Ihara Y., Ogata A., Yoshizaki K., Azuma J., Kishimoto T. Hypoxic stress induces cardiac myocyte-derived interleukin-6. Circulation. 1995 Mar 1;91(5):1520–1524. doi: 10.1161/01.cir.91.5.1520. [DOI] [PubMed] [Google Scholar]
  36. Yokoyama T., Vaca L., Rossen R. D., Durante W., Hazarika P., Mann D. L. Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart. J Clin Invest. 1993 Nov;92(5):2303–2312. doi: 10.1172/JCI116834. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES